...
首页> 外文期刊>American Journal of Physiology >Estradiol reverses TGF-beta1-stimulated type IV collagen gene transcription in murine mesangial cells.
【24h】

Estradiol reverses TGF-beta1-stimulated type IV collagen gene transcription in murine mesangial cells.

机译:雌二醇逆转小鼠系膜细胞中TGF-β1刺激的IV型胶原基因转录。

获取原文
获取原文并翻译 | 示例

摘要

We have previously shown that estradiol suppresses types I and IV collagen synthesis by mesangial cells grown in the presence of serum. In the present study, we examined the interaction between estradiol and transforming growth factor-beta (TGF-beta) on collagen IV synthesis. In a luciferase reporter gene construct containing the type IV collagen promoter and 1-chain regulatory sequences, we found that TGF-beta1 (2 ng/ml) stimulated alpha1-collagen IV gene transcription in serum-free media (140.5 +/- 6.2 relative luciferase units, expressed as a percent of control untreated cells, P < 0.001). Estradiol reversed the stimulatory effects of TGF-beta1 on reporter gene transcription in a dose-dependent manner [for 2.5 10(-9) M, 114.2 +/- 0.2, P < 0.002 vs. TGF-beta1; for 10(-7) M, 89.5 +/- 4.0, P < 0.001 vs. TGF-beta1 and P = not significant (NS) vs. control]. Using immunoprecipitation techniques, we found that estradiol (10(-7) M) reversed TGF-beta1-stimulated type IV collagen synthesis (175.3 +/- 14.7 vs. 111.6 +/- 7.1, expressed as a percent of control untreated cells, P < 0.001) but did not affect TGF-beta1-stimulated type I collagen synthesis (166.9 +/- 18.8 vs. 162.2 +/- 16.2, P = NS). These results were confirmed with Western blotting. Nuclear extracts from mesangial cells treated with TGF-beta1 showed increased binding to a Sp1 consensus binding sequence oligonucleotide and to an Sp1 binding site in the collagen IV promoter. Estradiol reversed this enhanced binding. These data suggest that estradiol antagonizes TGF-beta1-stimulated type IV collagen synthesis at a transcriptional level and that this effect may be mediated by interactions with the transcription factor Sp1.
机译:先前我们已经表明,雌二醇可以抑制在血清存在下生长的肾小球系膜细胞合成I型和IV型胶原。在本研究中,我们检查了雌二醇和胶原IV合成中转化生长因子-β(TGF-β)之间的相互作用。在包含IV型胶原启动子和1链调控序列的荧光素酶报告基因基因构建物中,我们发现TGF-beta1(2 ng / ml)在无血清培养基(相对值140.5 +/- 6.2)中刺激了alpha1-胶原IV基因转录。荧光素酶单位,表示为未处理的对照细胞的百分比,P <0.001)。雌二醇以剂量依赖的方式逆转了TGF-β1对报告基因的刺激作用[对于2.5 10(-9)M,114.2 +/- 0.2,P <0.002,相对于TGF-β1;对于10(-7)M,89.5 +/- 4.0,相对于TGF-beta1,P <0.001,相对于对照,P =不显着(NS)。使用免疫沉淀技术,我们发现雌二醇(10(-7)M)逆转了TGF-β1刺激的IV型胶原合成(175.3 +/- 14.7对111.6 +/- 7.1,表示为未经处理的对照细胞P的百分比<0.001),但不影响TGF-β1刺激的I型胶原合成(166.9 +/- 18.8与162.2 +/- 16.2,P = NS)。用Western印迹证实了这些结果。用TGF-β1处理的系膜细胞的核提取物显示与Sp1共有结合序列寡核苷酸和胶原IV启动子中Sp1结合位点的结合增加。雌二醇逆转了这种增强的结合。这些数据表明雌二醇在转录水平上拮抗TGF-β1刺激的IV型胶原合成,并且这种作用可能是通过与转录因子Sp1的相互作用介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号